Kairos Pharma Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
John Yu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 41.4% |
| Management average tenure | no data |
| Board average tenure | less than a year |
Recent management updates
No updates
Recent updates
No updates
CEO
John Yu (60 yo)
no data
Tenure
Dr. John S. Yu, M.D., Ph D., Founded ImmunoCellular Therapeutics, Ltd. He serves as a Chief Executive Officer, Chairman and Secretary at Kairos Pharma, Ltd.Since 2019, Dr. Yu has also served as the Chief...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chairman & Secretary | no data | no data | 41.4% $ 8.5m | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 4.2yrs | no data | 0.34% $ 70.9k | |
| Independent Director | less than a year | no data | no data |
0.2yrs
Average Tenure
57.5yo
Average Age
Experienced Board: KAPA's board of directors are not considered experienced ( 0.2 years average tenure), which suggests a new board.